SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Burning Rock Biotech Limited (BNR) News

Track canonical SquawkNews coverage tagged to BNR, Burning Rock Biotech Limited. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol BNR Asset equity Sector Markets 90 days 8 Last 18.99 Updated Sep 10, 2026, 11:29 AM UTC Open live news feed
L Burning Rock Biotech 2Q revenue $134.8M OverviewOutlookResult DriversCompany press release:Key DetailsReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact re EQUITY | Sep 10, 2026, 11:29 AM UTC L Burning Rock Biotech reports 2Q loss of $18.4M EQUITY | Sep 10, 2026, 11:17 AM UTC L BNR - Burning Rock Reports Second Quarter 2026 Financial Results BNR - Burning Rock Reports Second Quarter 2026 Financial Results EARNINGS | Sep 10, 2026, 11:17 AM UTC L Ifo says German chemical industry mood turns positive after four years Ifo reports German chemical industry mood turned positive for the first time in four years. EQUITY | Aug 28, 2026, 06:00 AM UTC L BNR announces exclusive distribution agreement with Zeus Hygia Life Sciences BNR announced an exclusive distribution agreement with Zeus Hygia Life Sciences. EQUITY | Aug 27, 2026, 08:28 AM UTC M DAX opens 0.40% higher as Fresenius leads gainers The DAX Index is up 105 points, or 0.40%, on Thursday, with Fresenius, Qiagen NV and Commerzbank among the top gainers while Brenntag, BASF and Hannover Rueck lag. EQUITY | Aug 13, 2026, 07:31 AM UTC L Burning Rock Biotech shares are trading higher after the company announced its founder, chairman and CEO, Yusheng Han, has purchased 73,141 Burning Rock Biotech shares are trading higher after the company announced its founder, chairman and CEO, Yusheng Han, has purchased 73,141 ADSs for $618,217.72. EQUITY | Jul 02, 2026, 06:33 PM UTC H Burning Rock Biotech Founding Chairman And CEO Mr. Yusheng Han Buys 73,141 BNR ADSs On Open Market For ~$618.2K As of the date of this press release, combined with 72,733 ADSs purchased in the last two post-earnings trading windows, Mr. Han has purchased an aggregate of 145,874 of the Company’s ADSs for US$1,976,542.90 across thre EARNINGS | Jul 02, 2026, 11:22 AM UTC